A fluorescent fatty acid probe, DAUDA, selectively displaces two myristates bound in human serum albumin

Protein Science

Volumn 20, Issue 12, 2011, Pages 2095-2101

  Wang, Yu ^a,b   Luo, Zhipu ^a,b   Shi, Xiaoli ^a   Wang, Huan ^c   Nie, Lei ^c   Huang, Mingdong ^a  

^a FUJIAN INSTITUTE OF RESEARCH ON THE STRUCTURE OF MATTER   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Zhejiang Hisun Pharmaceutical Co   (China)

Author keywords

Crystal structure; DAUDA; Fluorescent fatty acid analogue; Human serum albumin

Indexed keywords

11 (DANSYLAMINO)UNDECANOIC ACID; FATTY ACID; FATTY ACID DERIVATIVE; FLUORESCENT DYE; HUMAN SERUM ALBUMIN; MYRISTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; LIGAND BINDING; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; DANSYL COMPOUNDS; FATTY ACIDS; FLUORESCENT DYES; HUMANS; MODELS, MOLECULAR; MYRISTATES; PROTEIN BINDING; SERUM ALBUMIN;

EID: 81755172097     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.749     Document Type: Article

References (38)

1. Peters T (1996) All about albumin: biochemistry, genetics, and medical applications. San Diego: Academic Press. pp 432.
2. Fabisiak JP, Sedlov A, Kagan VE (2002) Quantification of oxidative/nitrosative modification of CYS34 in human serum albumin using a fluorescence-based SDS-PAGE assay. Antioxid Redox Signal 4:855-865. (Pubitemid 35246949)
3. Burch JW, Blazeryost B (1981) Acetylation of albumin by low-doses of aspirin. Thromb Res 23:447-452.
4. Hawkins D, Pinckard RN, Farr RS (1968) Acetylation of human serum albumin by acetylsalicylic acid. Science 160:780.
5. Huang MD, Yang F, Bian CB, Zhu LL, Zhao GX, Huang ZX (2007) Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin. J Struct Biol 157:348-355. (Pubitemid 46109335)
6. Curry S (2009) Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metab Pharmacol 24:342-357.
7. Sugio S, Kashima A, Mochizuki S, Noda M, Kobayashi K (1999) Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng 12:439-446. (Pubitemid 29322441)
8. Sudlow G, Birkett DJ, Wade DN (1975) Characterization of 2 specific drug binding-sites on human-serum albumin. Mol Pharmacol 11:824-832.
9. Sudlow G, Birkett DJ, Wade DN (1976) Further characterization of specific drug binding-sites on human-serum albumin. Mol Pharmacol 12:1052-1061.
10. He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358:209-215.
11. Zhu L, Yang F, Chen L, Meehan EJ, Huang M (2008) A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography. J Struct Biol 162:40-49.
12. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S (2005) Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 353:38-52. (Pubitemid 41338838)
13. Curry S, Mandelkow H, Brick P, Franks N (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 5:827-835. (Pubitemid 28402087)
14. Bhattacharya AA, Grune T, Curry S (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 303:721-732.
15. Simard JR, Zunszain PA, Ha CE, Yang JS, Bhagavan NV, Petitpas I, Curry S, Hamilton JA (2005) Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy. Proc Natl Acad Sci USA 102:17958-17963. (Pubitemid 41798484)
16. Thumser AEA, Wilton DC (1995) The binding of natural and fluorescent lysophospholipids to wild-type and mutant rat-liver fatty-acid-binding protein and albumin. Biochem J 307:305-311.
17. Guo S, Shi X, Yang F, Chen L, Meehan EJ, Bian C, Huang M (2009) Structural basis of transport of lysophospholipids by human serum albumin. Biochem J 423:23-30.
18. Lejon S, Frick IM, Bjorck L, Wikstrom M, Svensson S (2004) Crystal structure and biological implications of a bacterial albumin binding module in complex with human serum albumin. J Biol Chem 279:42924-42928. (Pubitemid 39372183)
19. Lejon S, Cramer JF, Nordberg P (2008) Structural basis for the binding of naproxen to human serum albumin in the presence of fatty acids and the GA module. Acta Cryst F64:64-69. (Pubitemid 351348062)
20. Thumser AEA, Buckland AG, Wilton DC (1998) Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site. J Lipid Res 39:1033-1038. (Pubitemid 28222008)
21. Wilton DC (1990) The fatty-acid analog 11-(dansylamino) undecanoic acid is a fluorescent-probe for the bilirubin-binding sites of albumin and not for the highaffinity fatty acid-binding sites. Biochem J 270:163-166.
22. Spector AA (1975) Fatty-acid binding to plasma albumin. J Lipid Res 16:165-179.
23. Petitpas I, Bhattacharya AA, Twine S, East M, Curry S (2001) Crystal structure analysis of warfarin binding to human serum albumin - anatomy of drug site I. J Biol Chem 276:22804-22809.
24. Bhattacharya AA, Curry S, Franks NP (2000) Binding of the general anesthetics propofol and halothane to human serum albumin - high resolution crystal structures. J Biol Chem 275:38731-38738. (Pubitemid 32009208)
25. Fersht AR, Shi JP, Knilljones J, Lowe DM, Wilkinson AJ, Blow DM, Brick P, Carter P, Waye MMY, Winter G. (1985) Hydrogen-bonding and biological specificity analyzed by protein engineering. Nature 314:235-238. (Pubitemid 15076511)
26. Zunszain PA, Ghuman J, McDonagh AF, Curry S (2008) Crystallographic analysis of human serum albumin complexed with 4Z,15E-bilirubin-IXalpha. J Mol Biol 381:394-406.
27. Wardell M, Wang ZM, Ho JX, Robert J, Ruker F, Ruble J, Carter DC (2002) The atomic structure of human methemalbumin at 1.9 angstrom. Biochem Biophys Res Commun 291:813-819. (Pubitemid 34694348)
28. Jacobsen J (1969) Binding of bilirubin to human serum albumin - determination of dissociation constants. FEBS Lett 5:112.
29. Simard JR, Zunszain PA, Hamilton JA, Curry S (2006) Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. J Mol Biol 361:336-351. (Pubitemid 44092787)
30. Chen YM, Guo LH (2009) Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin. Arch Toxicol 83:255-261.
31. Lissi E, Biasutti MA, Abuin E, Leon L (2009) A fluorescence study of human serum albumin binding sites modification by hypochlorite. J Photochem Photobiol B 94:77-81.
32. Mathias U, Jung M (2007) Determination of drug-serum protein interactions via fluorescence polarization measurements. Anal Bioanal Chem 388:1147-1156. (Pubitemid 47150035)
33. Nakajou K, Watanabe H, Kragh-Hansen U, Maruyama T, Otagiri M (2003) The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochim Biophys Acta 1623:88-97. (Pubitemid 37315665)
34. Ryan AJ, Ghuman J, Zunszain PA, Chung CW, Curry S (2011) Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin. J Struct Biol 174:84-91.
35. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymology. New York: Academic Press, pp 307-326.
36. Brunger AT, Adams PD, Clore GM, DeLano WL, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL (1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Cryst D54:905-921.
37. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Cryst D60:2126-2132. (Pubitemid 41742764)
38. The PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC.